Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | -0.044 | 0.5 |
mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.6 |
mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |